Early studies have shown the mosquito-borne virus can destroy cells responsible for glioblastoma, the most common form of brain cancer.
Glioblastoma affects 12,000 people per year in the United States, and was recently diagnosed in US Senator John McCain.
The standard treatment is chemotherapy and radiation. But most patients die within two years.
"It is so frustrating to treat a patient as aggressively as we know how, only to see his or her tumor recur a few months later," said Milan Chheda from Washington University School of Medicine in St. Louis.
The secret to Zika's apparent success, the latest experiments show, is that the virus specifically takes aim at brain cancer stem cells, the kind that tend to survive chemotherapy and spread.
When a pregnant woman is infected with Zika, she faces a higher risk of bearing an infant with an unusually small head because Zika destroys these very cells, leading to the irreversible condition known as microcephaly.
Zika tends to attack neuroprogenitor cells, which are common in fetuses but rare in adults.
Researchers injected either Zika virus or a saltwater placebo directly into the brain tumors of 33 mice, said the report in The Journal of Experimental Medicine.
Two weeks later "tumors were significantly smaller in the Zika-treated mice," said the report. These mice also survived "significantly longer than the ones given saltwater."
More work is needed before the treatment can be safely attempted in humans.
Extra studies on Zika's effects on the brain tissue of epilepsy patients showed the virus did not infect non- cancerous brain cells.
"We see Zika one day being used in combination with current therapies to eradicate the whole tumor," said Chheda.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
